CalcMyPeptide
All ProtocolsBeginner

Immune Resilience & Post-Viral Stack

Modulate robust T-cell activation, balance Th1/Th2 responses, and shield against viral pathogenesis through thymic regeneration.

Duration

4-8 weeks (or acute during infection)

First Results

1-2 weeks

Peptides in Stack

4

1Overview

A powerful "reset" of the immune system. Acute use during the onset of illness significantly truncates duration and severity. Chronic cyclical use restores thymic function, restoring the body's capacity to deploy intelligent, targeted T-cells.

Ideal Candidates

  • Individuals looking to fortify immune resilience during viral seasons
  • Those dealing with chronic viral reactivation (EBV, Lyme, Long-COVID)
  • Anyone struggling with dysregulated immune responses or age-related thymic involution

Contraindications

  • Patients undergoing immunosuppressive therapy (e.g., organ transplants)
  • Those with highly active, severe autoimmune diseases out of remission
  • Pregnant or breastfeeding women

2The Science

The thymus gland is the master university of the immune system, training T-cells to combat pathogens instead of attacking your own body. Uniquely, it degrades (involutes) heavily as we age. Thymosin Alpha-1 and Thymalin explicitly instruct the immune system to upregulate pathogen-destroying cells (Th1) while calming down hyper-allergic, inflammatory states (Th2), actively restoring youth-like immunity.


3Clinical Evidence

Moderate Evidence
30 human studies100 animal studies

Key Findings

1

Thymosin Alpha-1 (Zadaxin) is FDA-designated orphan drug for hepatitis B treatment, approved in 35+ countries worldwide

SciClone Pharmaceuticals, regulatory data

2

TA-1 significantly enhances CD4+, CD8+ T-cell, dendritic cell, and NK cell responses in immunocompromised patients

Multiple hepatitis/HIV clinical trials

3

Thymalin treatment in elderly cohorts associated with improved T-cell subset ratios and reduced infection rates

Khavinson, St. Petersburg Institute

4

TA-1 used as adjunctive therapy in viral hepatitis C showing improved viral clearance when combined with interferon

Phase 3 clinical data

5

Thymalin showed mortality reduction in elderly populations treated with 10-day courses bi-annually over 6+ years

Khavinson bioregulator studies

Study Limitations

  • Zadaxin (TA-1) is approved internationally but not FDA-approved for general immune enhancement in the US
  • Thymalin data primarily from Khavinson group; independent replication limited
  • Optimal cycling protocols (frequency, duration) not established in rigorous RCTs
  • Use in active autoimmune disease requires careful risk-benefit assessment (may exacerbate)
  • Quality varies significantly between compounded TA-1 products and pharmaceutical-grade Zadaxin

3The Peptide Stack

TH

Thymosin Alpha-1

View Profile →

An FDA-approved orphan drug (Zadaxin) that functions as a major endogenous regulator of immune homeostasis, profoundly enhancing T-cell, dendritic, and NK cell responses.

Half-life: ~2 hoursDose range: 1.6-3.2 mg twice weekly
TH

Khavinson bioregulator peptide that penetrates the thymus directly, upregulating gene expression to reverse thymic involution and restore baseline immune capacity.

Mechanism: Low-molecular-weight peptide acting directly on thymic tissue to restore functional T-cell maturation. Works through transcriptomic signaling to reverse age-related thymic shrinkage.

Half-life: ~30 minutesDose range: 10 mg/day for 10 days
LL

Endogenous antimicrobial peptide (cathelicidin) acting as the body's first line of defense against bacterial, viral, and fungal pathogens, while recruiting immune cells to infection sites.

Mechanism: Punctures bacterial cell membranes and binds to LPS to prevent endotoxic shock, while simultaneously agonizing formyl peptide receptors to enhance immune signaling.

Half-life: ~4 hours (estimated)Dose range: 50-200 mcg/day
KP

Ultra-potent natural tripeptide that regulates mast cells and drives down systemic inflammation without suppressing the immune system's ability to fight pathogens.

Mechanism: Penetrates cells directly to inhibit NF-κB (the master switch for inflammation), shutting down hyper-inflammatory cytokine storms often seen in severe microbial infections.

Half-life: ~30 minutes (estimated)Dose range: 200-500 mcg/day

4Protocol Tiers

Acute Viral Defense

Deploy at the very first sign of influenza, respiratory infection, or viral reactivation.

Duration
7-14 Days
Frequency: Daily
Timing: Once daily subcutaneous injection until symptoms fully resolve
Clinical Note: Efficacy is highest when administered at the earliest onset of symptoms.
KPV250-500 mcg
Timing: Once or twice daily
Clinical Note: Added to calm severe systemic inflammation, cytokine storms, or excessive mucosal/respiratory inflammation.

The Thymic Master-Reset

Deep, systemic immune rejuvenation to structurally repair the thymus.

Duration
10-20 Days (Run bi-annually)
Frequency: Daily
Timing: Administered daily for 10-20 consecutive days
Clinical Note: Unlike TA-1 which is used acutely, Thymalin is best run cyclically bi-annually.

Heavy Antimicrobial Sweep

Targeted for resistant bacterial, fungal, or complex biofilm pathogencity (e.g., Lyme, SIBO, Candida).

Duration
4-6 Weeks
Frequency: Daily
LL-37100-200 mcg
Timing: Once daily
Clinical Note: Potent and broad-spectrum antimicrobial; titrate slowly to avoid aggressive Herxheimer die-off reactions.

5Lifestyle Integration

Peptides are one input in a larger system. Without these non-negotiable lifestyle factors, even the best protocol will underperform.

🏋️Training

Moderate cardiovascular exercise promotes lymphatic drainage (crucial for clearing pathogen debris). Conversely, extreme endurance training during acute illness suppresses the nervous system and prolongs sickness.

🥗Nutrition

A heavily nutrient-dense diet focusing on Vitamin D3 (mandatory for immune signaling), Zinc, and Vitamin C. Avoid ultra-processed sugars, which paralyze white blood cell phagocytosis for hours post-consumption.

🌙Sleep

Sleep is non-negotiable. Pro-inflammatory cytokines involved in fighting infection are heavily released during slow-wave sleep. Depriving sleep during a protocol destroys its efficacy.

🧘Stress Management

Psychological stress skyrockets cortisol. High cortisol literally induces apoptosis (death) in lymphocytes (immune cells). Active stress mitigation is vital.

6Timeline & Expectations

Days 1-5 (Acute)

What You'll NoticeStabilization or rapid truncation of active viral symptoms (reduced severity of fatigue, fever breaks faster).
What's Happening BiologicallyTA-1 forces a massive deployment and coordination of CD4+ and CD8+ T-cells to specifically swarm the pathogen.

Weeks 2-4 (Chronic/Reset)

What You'll NoticeLifting of chronic fatigue, reduced incidence of catching ambient colds, and an overall feeling of systemic resilience.
What's Happening BiologicallyThymalin has triggered transcriptomic signaling in the thymus. New, properly "trained" immune cells are saturating the lymphatic system.

7Monitoring & Safety

Key Metrics to Track

Subjective Health TrackingLog the duration and severity of ambient illnesses (e.g., "how long does a cold bench me vs. a year ago?").
CD4/CD8 Count & T-Cell SubsetsAdvanced blood panel for precise tracking of immune cell proliferation.

Troubleshooting

Mild localized skin redness at the injection site
Possible Causes
  • Normal peptide immune response (TA-1 and Thymalin are literally generating a rapid immune cascade)
Solutions
  • Totally normal. Rotate injection sites. Do not inject into existing bruised tissue.

8Further Reading

Dive deeper into the individual peptides and methodologies behind this protocol.